Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINOX: Minoxidil 5% Foam for Androgenetic Alopecia in Men
NCT04721548Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by Eurofarma. Started Mar 2023; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT04721548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04721548.